Results
Out of all 1485 patients with cervical dysplasia and cervical cancer precursors (including diagnosis PAP III, IIID, IV and CIN I, II, III) 55,2% were HPV high-risk positive. In 29.5% infection with HPV 16, and in 6.1% HPV 18 could be detected. Furthermore, referring to vaccination cross immunity HPV 31, 33, 45, and 52 were detected in 14,9% 7,7% , 2,9% and 6,2% respectively. Out of 1149 patients with diagnosis "suspected HPV" 46% showed HPV high-risk positivity. Out of patients with diagnosis "control/ control of partner" (n=141) 53% and with diagnosis "erosion of portio" (n=185) 17% were HPV high-risk positive.
The identification of genotypes evaluated for different age groups (20 to 30 and 50 to 60 years) in patients with cervical dysplasia and cervical cancer precursors shows that both types, HPV 16 and 18, were more often detected in young women and decreased with increasing age. In contrast, an increase of HPV high-risk types other than 16 and 18, such as HPV 45 and 56, were more often identified in older women. In the group of individuals with genital warts (n=558), HPV low-risk types were detected in 42.8%. The genotyping showed a higher detection rate of HPV 6 (60,7%) compared with HPV 11 (10,5%). Interestingly, when material was sampled directly in the Outpatients' Centre from genital warts (n=248) 65,3% showed infection with HPV low-risk types. In contrast, when material was collected by the referring physician out of 310 patients only 24,8% (n=77) turned out to be positive for HPV low-risk. The difference is highly significant (p < 0,001). 65,3%
